the company During the past 6 months Will have the transaction size equal to 11.67 percent according to the Total value of consideration paid or received basis Which is the calculation criterion which

Notifications”). The transaction size is 1.29 percent as calculated based on the total value of consideration criterion which granted the highest result, referenced from the consolidated audited financial

5.8 Manufacture and skincare products, cosmetics, food supplements and medicine used to treat skin diseases segment 9,708 2.2 13,124 3.2 (3,416) (26.0) total 443,248 100.0 417,617 100.0 25,631 6.1 The

32.6 Debt Service Coverage 904.1 4.4 103.9 4.6 Total Debt to Equity 0.2 0.4 0.2 0.4 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine

operations for 2nd Quarter of 2017 decreased to 71.69%, while it was 74.38% for the 2nd Quarter of 2016. These resulted from the efficiency of medicine and medical supplies cost management, introducing an

personnel to support its expansion such as Cardiac Medicine department and Opthalmology department. Selling Expenses For the 6-month periods of 2015 and 2016 , the Company and its subsidiary incurred selling

Totabl Debt to Equity 0.13 0.25 * based on only cost of medicine & medical supplies

medicine & medical supplies

53.7 Debt Service Coverage 673.5 10.1 Total Debt to Equity 0.2 0.3 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine & medical

needs to calculate the transaction size percentage by considering four criteria. The total size of the Transaction calculated based on the total value of consideration criterion, gives the highest